The company is involved with the creation of significant biotechnology research capabilities in the area of targeted human therapeutic proteins. The Current status of the project has reached preclinical evaluation. Knowing the superiority of the technology and export market Century has decided to conduct the preclinical activity in aboard on transgenic animals.
This plat form technology has been successfully demonstrated at clinical level make the pavement to develop biomolecules for signal and receptor mediated diseases using this technology like cancer. Human phase-1 clinical trial is expected in 2017.
We are the first SME organization to start this new business model of a “Research Boutique”.

Fusion protein
Mast cell
Asthma and allergy
Pledged to develop drug candida